BHCM
IRON icon

Brevan Howard Capital Management’s Disc Medicine IRON Stock Holding History

Brevan Howard Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.66M Buy
49,996
+17,590
+54% +$1.21M 0.03% 468
2026
Q1 		$2.04M Sell
32,406
-17,307
-35% -$1.2M 0.02% 551
2025
Q4 		$3.89M Buy
+49,713
New +$4.2M 0.04% 295
2025
Q1 		– Sell
-6,213
Closed -$394K – 1307
2024
Q4 		$394K Buy
+6,213
New +$359K ﹤0.01% 698
2024
Q3 		– Sell
-6,642
Closed -$299K – 1288
2024
Q2 		$299K Buy
+6,642
New +$226K ﹤0.01% 782

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Brevan Howard Capital Management's IRON Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Disc Medicine (IRON) stake by 54% in Q2 2026, buying an estimated $1.21M and bringing the position to 49,996 shares worth $3.66M. The position accounts for 0.03% of the portfolio, ranked #468.

Brevan Howard Capital Management first reported a position in IRON in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.89M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Brevan Howard Capital Management held 49,996 shares of Disc Medicine worth $3.66M as of Q2 2026.
  • Brevan Howard Capital Management bought 17,590 Disc Medicine shares in Q2 2026, an estimated $1.21M.
  • Disc Medicine made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #468 holding.
  • Brevan Howard Capital Management first reported a position in Disc Medicine in Q2 2024 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's Disc Medicine position peaked at $3.89M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.